Related Experiment Video
Updated: Jun 14, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Post COVID-19 conditions in an Australian pediatric cohort, 3 months following a Delta outbreak
Philip N Britton1,2,3, Rebecca Burrell4,5, Emily Chapman6
1The Children's Hospital at Westmead Clinical School, Sydney Medical School, the University of Sydney, Westmead, NSW, Australia. philip.britton@health.nsw.gov.au.
Insights
Pediatric Long COVID is infrequent in Australian children, with most recovering within 12 weeks. However, a minority experience persistent symptoms, highlighting the need for ongoing attention to post-COVID conditions.
Area of Science:
- Pediatric infectious diseases
- Public health surveillance
- Clinical immunology
Background:
- Pediatric long COVID remains poorly understood, with limited Australian data.
- The 2021 Delta variant outbreak provided a specific cohort for study.
Purpose of the Study:
- To assess symptoms and functional impairment 12 weeks post-infection in Australian children and adolescents.
- To evaluate the impact of the SARS-CoV-2 Delta variant on pediatric recovery.
Main Methods:
- Online survey distributed to parents/carers of 11,864 PCR-confirmed SARS-CoV-2 cases.
- Assessment of symptoms and functional impairment at 12 weeks post-infection.
- Clinical review for patients reporting non-recovery.
Main Results:
- 17.6% of invited parents responded to the survey.
- 11.7% reported persistent symptoms or functional impairment.
- Of those reviewed, 37.3% had Post COVID Conditions (PCC), and 12.4% met Long COVID criteria.
Conclusions:
- Self-reported non-recovery in children is infrequent but warrants attention.
- Long COVID is a subset of non-recovery cases, affecting a minority of pediatric patients.
- Risk factors for pediatric post-COVID conditions include age over 11 and pre-existing comorbidities.
Background:
Pediatric long COVID remains incompletely understood with scant Australian data available. We aimed to assess the impacts of the 2021 Delta variant of SARS-CoV-2 outbreak on symptoms and functioning 12 weeks post-acute infection in a cohort of children and adolescents.
Methods:
The parents/carers of 11,864 patients with PCR-confirmed SARS-CoV-2 were invited, via email or text message, to complete an online survey assessing symptoms and functional impairment.
Findings:
1731 (17.6%) responded to the survey. 203 (11.7%) reported continued symptoms and/or functional impairment which were flagged for clinical review, all others reported recovery. Of the 169 subsequently clinically reviewed, 63 had already recovered (37.3%) and 17 had exacerbation of pre-existing condition(s) (10.1%); 63 (37.3%) were diagnosed with a Post COVID Condition (PCC). Of these, 21 (12.4%) were considered to have features compatible with the United Kingdom consensus cases definition for Long COVID.
Interpretation:
During an outbreak of SARS-CoV-2 an online questionnaire with subsequent clinical review revealed self-reported non-recovery at 12 weeks in a minority of cases, with a spectrum of features. Long COVID comprised only a subset of cases with self-reported non-recovery, and is infrequent in children and adolescents, but still comprises a likely significant burden that warrants attention.
Impact:
Our study provides the only comprehensive estimate of the frequency and spectrum of post-COVID conditions in children from Australia. The high frequency of self-reported recovery, and low frequency of Long COVID compatible illness adds to the literature from other settings. Risk factors for post-COVID conditions in children are identified and include: age >11 year, and previous medical co-morbidity.
Related Concept Videos
Pulmonary Cycle: Exhalation
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

